[1]
Gallo, L., Capasso, G., Nastro, F., Fabbrocini, G. and Megna, M. 2022. Adalimumab Biosimilar Efficacy and Safety in a 5-Year-Old Patient with Severe Plaque Psoriasis During SARS-CoV-2 Pandemic Outbreak. Open Access Macedonian Journal of Medical Sciences. 10, C (May 2022), 257–260. DOI:https://doi.org/10.3889/oamjms.2022.7575.